USP Drug Classification

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Analgesics
 
 Anesthetics
 
 Anti-Addiction/Substance Abuse Treatment Agents
 
 Antibacterials
 
 Anticonvulsants
 
 Antidementia Agents
 
 Antidepressants
 
 Antiemetics
 
 Antifungals
 
 Antigout Agents
 
 Anti-inflammatory Agents
 
 Antimigraine Agents
 
 Antimyasthenic Agents
 
 Antimycobacterials
 
 Antineoplastics
   Alkylating Agents
   Antiandrogens
   Antiangiogenic Agents
   Antiestrogens/Modifiers
   Antimetabolites
   Aromatase Inhibitors, 3rd Generation
   Enzyme Inhibitors
   Molecular Target Inhibitors
     Gefitinib
     Alectinib [DG:DG01625]
     Ceritinib
     Vemurafenib
     Dabrafenib [DG:DG00721]
     Trametinib [DG:DG00723]
     Ibrutinib
     Palbociclib [DG:DG01831]
     Ramucirumab
     Afatinib [DG:DG00717]
     Erlotinib [DG:DG00711]
       D07907  Erlotinib (INN)
       D04023  Erlotinib hydrochloride (JAN/USAN)
     Osimertinib
     Sonidegib [DG:DG01854]
     Vismodegib
     Ruxolitinib [DG:DG00719]
     Cabazitaxel [DG:DG00695]
     Everolimus
     Crizotinib
     Bosutinib [DG:DG00718]
     Dasatinib [DG:DG00714]
     Imatinib [DG:DG00710]
     Nilotinib [DG:DG00716]
     Ponatinib [DG:DG00722]
     Lapatinib [DG:DG00715]
     Axitinib
     Cabozantinib [DG:DG01670]
     Lenvatinib [DG:DG01362]
     Pazopanib
     Regorafenib [DG:DG00720]
     Sorafenib [DG:DG00713]
     Sunitinib [DG:DG00712]
     Vandetanib
     Idelalisib
     Olaparib
     Venetoclax [DG:DG02114]
     Belinostat
     Panobinostat [DG:DG01403]
   Monoclonal Antibody/Antibody-Drug Conjugate
   Retinoids
   Treatment Adjuncts
   Antineoplastics, Other
 
 Antiparasitics
 
 Antiparkinson Agents
 
 Antipsychotics
 
 Antispasticity Agents
 
 Antivirals
 
 Anxiolytics
 
 Bipolar Agents
 
 Blood Glucose Regulators
 
 Blood Products/Modifiers/Volume Expanders
 
 Cardiovascular Agents
 
 Central Nervous System Agents
 
 Dental and Oral Agents
 
 Dermatological Agents
 
 Electrolytes/Minerals/Metals/Vitamins
 
 Gastrointestinal Agents
 
 Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
 
 Genitourinary Agents
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 
 Hormonal Agents, Suppressant (Adrenal)
 
 Hormonal Agents, Suppressant (Pituitary)
 
 Hormonal Agents, Suppressant (Thyroid)
 
 Immunological Agents
 
 Inflammatory Bowel Disease Agents
 
 Metabolic Bone Disease Agents
 
 Ophthalmic Agents
 
 Otic Agents
 
 Respiratory Tract/Pulmonary Agents
 
 Skeletal Muscle Relaxants
 
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 12, 2017
According to the USP Medicare Model Guidelines v7.0

» Japanese version